| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |